How much revenue did Avicanna generate this year?
Avicanna has achieved a revenue of 21.42 M CAD this year.
Avicanna Revenue 2024
Avicanna Revenue
21.42 M CAD
Ticker
AVCN.TO
ISIN
CA05368K1003
WKN
A2PN04
In 2024, Avicanna's sales reached 21.42 M CAD, a 27.56% difference from the 16.79 M CAD sales recorded in the previous year.
The Avicanna Revenue history
| YEAR | REVENUE (undefined CAD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 35.01 | 21,77 |
| 2025e | 29.26 | 26,05 |
| 2024e | 21.42 | 35,58 |
| 2023 | 16.79 | 45,38 |
| 2022 | 4.05 | 46,17 |
| 2021 | 3.27 | 41,90 |
| 2020 | 1.57 | 67,52 |
| 2019 | 0.17 | 35,29 |
| 2018 | 0.12 | 6350,46 |
| 2017 | 0.03 | 25401,83 |
| 2016 | - | - |
Avicanna Revenue, EBIT, Net Income CA05368K1003 · A2PN04
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Avicanna, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Avicanna from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Avicanna’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Avicanna. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Avicanna’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Avicanna’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Avicanna’s growth potential.
Avicanna Revenue, EBIT and net profit per share
| Date | Avicanna Revenue | Avicanna EBIT | Avicanna Net Income |
|---|---|---|---|
| 2026e | 35.01 M undefined | 33,006.15 undefined | 269,655.23 undefined |
| 2025e | 29.26 M undefined | 114,901.96 undefined | 735,423.3 undefined |
| 2024e | 21.42 M undefined | 408,000 undefined | 2.05 M undefined |
| 2023 | 16.79 M undefined | -7.42 M undefined | -8.74 M undefined |
| 2022 | 4.05 M undefined | -9.66 M undefined | -14.74 M undefined |
| 2021 | 3.27 M undefined | -12.87 M undefined | -16.77 M undefined |
| 2020 | 1.57 M undefined | -16.64 M undefined | -32.86 M undefined |
| 2019 | 170,000 undefined | -23.25 M undefined | -21.07 M undefined |
| 2018 | 120,000 undefined | -8.33 M undefined | -7.1 M undefined |
| 2017 | 30,000 undefined | -2.59 M undefined | -2.6 M undefined |
| 2016 | 0 undefined | -30,000 undefined | -30,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2016 | 0 CAD | -30,000 CAD | -30,000 CAD |
| 2017 | 30,000 CAD | -2.59 M CAD | -2.6 M CAD |
| 2018 | 120,000 CAD | -8.33 M CAD | -7.1 M CAD |
| 2019 | 170,000 CAD | -23.25 M CAD | -21.07 M CAD |
| 2020 | 1.57 M CAD | -16.64 M CAD | -32.86 M CAD |
| 2021 | 3.27 M CAD | -12.87 M CAD | -16.77 M CAD |
| 2022 | 4.05 M CAD | -9.66 M CAD | -14.74 M CAD |
| 2023 | 16.79 M CAD | -7.42 M CAD | -8.74 M CAD |
| 2024e | 21.42 M CAD | 408,000 CAD | 2.05 M CAD |
| 2025e | 29.26 M CAD | 114,901.96 CAD | 735,423.3 CAD |
| 2026e | 35.01 M CAD | 33,006.15 CAD | 269,655.23 CAD |
Avicanna stock margins CA05368K1003 · A2PN04
The Avicanna margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Avicanna. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Avicanna.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Avicanna's sales revenue. A higher gross margin percentage indicates that the Avicanna retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Avicanna's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Avicanna's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Avicanna's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Avicanna. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Avicanna's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Avicanna Margin History
| Avicanna Gross margin | Avicanna Profit margin | Avicanna EBIT margin | Avicanna Profit margin |
|---|---|---|---|
| 2026e | 45.38 % | 0.09 % | 0.77 % |
| 2025e | 45.38 % | 0.39 % | 2.51 % |
| 2024e | 45.38 % | 1.9 % | 9.55 % |
| 2023 | 45.38 % | -44.18 % | -52.07 % |
| 2022 | 46.17 % | -238.52 % | -363.95 % |
| 2021 | 41.9 % | -393.58 % | -512.84 % |
| 2020 | 67.52 % | -1,059.87 % | -2,092.99 % |
| 2019 | 35.29 % | -13,676.47 % | -12,394.12 % |
| 2018 | 45.38 % | -6,941.67 % | -5,916.67 % |
| 2017 | 45.38 % | -8,633.33 % | -8,666.67 % |
| 2016 | 45.38 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2016 | 45.38 % | 0 % | 0 % |
| 2017 | 45.38 % | -8,633.33 % | -8,666.67 % |
| 2018 | 45.38 % | -6,941.67 % | -5,916.67 % |
| 2019 | 35.29 % | -13,676.47 % | -12,394.12 % |
| 2020 | 67.52 % | -1,059.87 % | -2,092.99 % |
| 2021 | 41.9 % | -393.58 % | -512.84 % |
| 2022 | 46.17 % | -238.52 % | -363.95 % |
| 2023 | 45.38 % | -44.18 % | -52.07 % |
| 2024e | 45.38 % | 1.9 % | 9.55 % |
| 2025e | 45.38 % | 0.39 % | 2.51 % |
| 2026e | 45.38 % | 0.09 % | 0.77 % |
Avicanna Aktienanalyse
What does Avicanna do?
Avicanna Inc is a Canadian biopharmaceutical company specializing in the research, development, and manufacturing of medical marijuana products. The company was founded in 2016 by its president and CEO Aras Azadian, who has extensive experience in the pharmaceutical and biotechnology industry. The company is based in Toronto, Canada and also operates in Colombia and Switzerland. Avicanna has several subsidiaries, including Santa Marta Golden Hemp, which operates its cultivation business in Colombia. Avicanna's business model is focused on producing medical marijuana products that have better efficacy and tolerability than conventional products. The company uses a specialized process called PhytoVista™ to isolate and extract the active ingredients in plant extracts. Avicanna operates in various sectors, including the manufacturing and marketing of medical marijuana products, research and development of effective medical treatments, and collaboration with healthcare facilities and government agencies in marijuana regulation. The company offers a variety of products, including different types of hemp oil, CBD products, and pharmaceutical products such as Rho PhytoTM and Pura EarthTM. These products all share the common approach of providing patients with better, more effective, and tolerable treatment options. Rho PhytoTM is a patented medical marijuana product by Avicanna, derived from a specific cannabis strain called ACMPR. This product is approved in Canada and available as an oral solution and syringe. Rho PhytoTM is specifically tailored to meet the needs of patients with neurodegenerative diseases and has proven to be effective. Pura EarthTM is a herbal remedy derived from the medical marijuana plant and is intended to be used as an alternative medicine for pain and inflammation. In addition to manufacturing medical marijuana products, the company also conducts intensive research and development to develop medications based on synthetic cannabinoids. These substances have the potential to help patients with various conditions such as multiple sclerosis, epilepsy, and tumor diseases. Avicanna also has partnerships with various healthcare facilities and government agencies to advance the regulation of medical marijuana and ensure the safety and efficacy of these products. In summary, Avicanna is an innovative biopharmaceutical company specializing in the manufacturing and marketing of medical marijuana products. The company serves various areas within the marijuana industry, including the production of medical products, research and development, and regulation of marijuana products. With an extensive product range and a strong research and development department, Avicanna is well positioned to continue growing and developing more innovative products in the coming years. Avicanna ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Avicanna's Sales Figures
The sales figures of Avicanna originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Avicanna’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Avicanna's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Avicanna’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Avicanna stock
How much was the turnover of the company Avicanna compared to the previous year?
The revenue of Avicanna has increased by 27.56% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Avicanna?
The revenue of Avicanna is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Avicanna measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Avicanna so important for investors?
The revenue of Avicanna is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Avicanna pay?
Over the past 12 months, Avicanna paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avicanna is expected to pay a dividend of 0 CAD.
What is the dividend yield of Avicanna?
The current dividend yield of Avicanna is .
When does Avicanna pay dividends?
Avicanna pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Avicanna?
Avicanna paid dividends every year for the past 0 years.
What is the dividend of Avicanna?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Avicanna located?
Avicanna is assigned to the 'Health' sector.
Wann musste ich die Aktien von Avicanna kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Avicanna from 8/27/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 8/27/2024.
When did Avicanna pay the last dividend?
The last dividend was paid out on 8/27/2024.
What was the dividend of Avicanna in the year 2023?
In the year 2023, Avicanna distributed 0 CAD as dividends.
In which currency does Avicanna pay out the dividend?
The dividends of Avicanna are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Avicanna stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Avicanna
Our stock analysis for Avicanna Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avicanna Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
